Gulf Pharmaceutical Industries P.S.C. financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
487.93M 544.60M 576.38M 541.50M 625.29M 762.04M 920.24M 1.02B 1.18B 1.36B 1.39B 1.47B 1.45B 1.15B 719.80M 301.50M 581.20M 1.14B 1.62B 1.64B 0.00M
GM % Gross Margin %
49.33% 51.82% 55.31% 57.83% 57.09% 59.68% 58.91% 61.29% 59.08% 60.25% 58.97% 61.83% 60.72% 45.73% 21.26% -22.72% 32.33% 33.54% 30.85% 100.00% 0.00%
OM Operating Margin
14.31% 13.94% 17.54% 18.44% 15.32% 18.69% 17.35% 18.17% 17.92% 16.44% 14.67% 16.46% 12.68% 7.91% -35.75% -154.56% -43.39% 3.63% -1.77% -1.87% 0.00%
EPS Earnings Per Share
0.37 0.37 0.32 0.14 -0.94 -0.02 -0.02 0.00
Div. Dividends
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.23 0.00 0.27 0.17 0.00 0.00 0.00 0.00 0.01 0.01 0.00
PR % Payout Ratio %
0 0 0 0 0 0 0 0 0 0 62.16% 0 84.38% 121.43% -0.00% 0 0 0 -50.00% -50.00% 0
Sha. Shares
476.9m 510.28m 525.82m 622.12m 622.12m 622.12m 622.12m 622.12m 622.12m 622.12m 655.23m 655.23m 655.23m 655.25m 655.25m 655.23m 1155.23m 1155.23m 1155.23m 0m 1155.23m
OCF Operating Cash Flow
58.07M 14.90M 165.61M 38.91M 63.12M 167.37M 120.63M 203.95M 171.31M 108.11M 39.60M 182.50M 267.60M 81.20M 178.70M -84.60M -166.20M 45.80M 19.30M 0.00M 0.00M
FCF Free Cash Flow
10.97M -15.47M 114.72M -65.33M -122.28M 31.97M -73.36M -29.80M 33.86M 16.45M -39.58M 88.20M 164.50M -5.10M 150.80M -119.30M -182.30M 1.40M -44.40M -90.50M 0.00M
FCFS Free Cash Flow Per Share
0.02 -0.04 0.23 -0.13 -0.17 0.05 -0.12 -0.05 0.05 0.03 -0.06 0.13 0.25 -0.01 0.19 -0.18 -0.17 0.00 -0.04 0.00 0.00